 |
|
Gentamicin Tissue Accumulation and Nephrotoxic Reactions
Jerome J. Schentag, PharmD;
Thomas J. Cumbo, MD;
William J. Jusko, PhD;
Martin E. Plaut, MD
JAMA. 1978;240(19):2067-2069.
Abstract
In 64 adults treated with gentamicin sulfate, peak and trough serum concentrations rose gradually and declined in two phases after the final dose. Seventeen patients experienced renal damage. The 17 patients had greater amounts of gentamicin in tissues even after the first dose and before any renal effects were noted. This pharmacokinetic analysis provided evidence that patients who experience gentamicin-related nephrotoxic effects while receiving recommended doses of gentamicin could be distinguished from patients with no toxic effects because they experienced abnormal tissue accumulation before detectable changes in renal function occurred.
(JAMA 240:2067-2069, 1978)
Author Affiliations
From the Departments of Pharmaceutics (Drs Schentag and Jusko) and Medicine (Drs Cumbo and Plaut), the Clinical Pharmacokinetics Laboratory, Millard Fillmore and Buffalo General Hospitals, State University of New York at Buffalo.
Footnotes
Reprint requests to Clinical Pharmacokinetics Laboratory, Millard Fillmore Hospital, 3 Gates Circle, Buffalo, NY 14209 (Dr Schentag).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Liposomal tobramycin against pulmonary infections of Pseudomonas aeruginosa: a pharmacokinetic and efficacy study following single and multiple intratracheal administrations in rats
Marier et al.
J Antimicrob Chemother 2003;52:247-252.
ABSTRACT
| FULL TEXT
Laboratory guidelines for monitoring of antimicrobial drugs
Hammett-Stabler and Johns
Clin. Chem. 1998;44:1129-1140.
ABSTRACT
| FULL TEXT
Exaggerated Response to Gentamicin-Induced Nephrotoxicity in Sprague-Dawley Rats: Identification of a Highly Sensitive Outlier Population
Frazier et al.
Toxicol Pathol 1986;14:204-209.
ABSTRACT
|
